PUBLISHER: TechNavio | PRODUCT CODE: 2144815
PUBLISHER: TechNavio | PRODUCT CODE: 2144815
Global Poly (Lactic-Co-Glycolic Acid) (PLGA) Market 2026-2030
The global poly (lactic-co-glycolic acid) (PLGA) market is forecasted to grow by USD 172100.3 thousand during 2025-2030, accelerating at a CAGR of 9.9% during the forecast period. The report on the global poly (lactic-co-glycolic acid) (PLGA) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by expanding long acting injectable drug demand, rising regenerative medicine scaffolding applications, advancements in targeted nanomedicine platforms.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 9.2% |
| CAGR | 9.9% |
| Incremental Value | $172100.3 thousand |
Technavio's global poly (lactic-co-glycolic acid) (PLGA) market is segmented as below:
By Application
- Personal care and dermatology
- Suture
- Fracture fixation
- Others
By Type
- PLGA 50/50
- PLGA 75/25
- PLGA 85/15
- PLGA 65/35
By Product Type
- Microspheres
- Nanoparticles
- Films
- Hydrogels
- Others
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- APAC
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- South America
- Brazil
- Argentina
- Chile
- Middle East and Africa
- UAE
- South Africa
- Turkey
- Rest of World (ROW)
This study identifies the shift towards ultrapure monomer formulations as one of the prime reasons driving the global poly (lactic-co-glycolic acid) (PLGA) market growth during the next few years. Also, adoption of microfluidic continuous manufacturing and development of transdermal microneedle delivery will lead to sizable demand in the market.
The report on the global poly (lactic-co-glycolic acid) (PLGA) market covers the following areas:
- Global poly (lactic-co-glycolic acid) (PLGA) market sizing
- Global poly (lactic-co-glycolic acid) (PLGA) market forecast
- Global poly (lactic-co-glycolic acid) (PLGA) market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global poly (lactic-co-glycolic acid) (PLGA) market vendors that include Akina Inc., Ashland Inc., Bezwada Biomedical LLC, BrightCN, Corbion N.V., Creative PEGWorks, DSM Firmenich AG, Evonik Industries AG, Geon Performance Solutions, Gunze Ltd., Kureha Corp., Merck KGaA, Mitsui Chemicals Inc., Nanosoft Polymers, Poly Med Inc., Polysciences Inc., RXNDT International, Science and Bio Material, SEQENS GROUP, Toray Industries Inc.. Also, the global poly (lactic-co-glycolic acid) (PLGA) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Product Type
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global Poly (Lactic-Co-Glycolic Acid) (PLGA) Market 2020 - 2024
- Historic Market Size - Data Table on Global Poly (Lactic-Co-Glycolic Acid) (PLGA) Market 2020 - 2024 ($ thousand)
- 5.2 Application segment analysis 2020 - 2024
- Historic Market Size - Application Segment 2020 - 2024 ($ thousand)
- 5.3 Type segment analysis 2020 - 2024
- Historic Market Size - Type Segment 2020 - 2024 ($ thousand)
- 5.4 Product Type segment analysis 2020 - 2024
- Historic Market Size - Product Type Segment 2020 - 2024 ($ thousand)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ thousand)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ thousand)
6 Qualitative Analysis
- 6.1 Impact of AI on global poly (lactic-co-glycolic acid) (PLGA) market
- 6.2 Impact of geopolitical conflicts on global poly (lactic-co-glycolic acid) (PLGA) market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by Application
- 8.1 Market segments
- 8.2 Comparison by Application
- 8.3 Personal care and dermatology - Market size and forecast 2025-2030
- 8.4 Suture - Market size and forecast 2025-2030
- 8.5 Fracture fixation - Market size and forecast 2025-2030
- 8.6 Others - Market size and forecast 2025-2030
- 8.7 Market opportunity by Application
- Market opportunity by Application ($ thousand)
9 Market Segmentation by Type
- 9.1 Market segments
- 9.2 Comparison by Type
- 9.3 PLGA 50/50 - Market size and forecast 2025-2030
- 9.4 PLGA 75/25 - Market size and forecast 2025-2030
- 9.5 PLGA 85/15 - Market size and forecast 2025-2030
- 9.6 PLGA 65/35 - Market size and forecast 2025-2030
- 9.7 Market opportunity by Type
- Market opportunity by Type ($ thousand)
10 Market Segmentation by Product Type
- 10.1 Market segments
- 10.2 Comparison by Product Type
- 10.3 Microspheres - Market size and forecast 2025-2030
- 10.4 Nanoparticles - Market size and forecast 2025-2030
- 10.5 Films - Market size and forecast 2025-2030
- 10.6 Hydrogels - Market size and forecast 2025-2030
- 10.7 Others - Market size and forecast 2025-2030
- 10.8 Market opportunity by Product Type
- Market opportunity by Product Type ($ thousand)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
- 12.4 Europe - Market size and forecast 2025-2030
- 12.4.1 Germany - Market size and forecast 2025-2030
- 12.4.2 UK - Market size and forecast 2025-2030
- 12.4.3 France - Market size and forecast 2025-2030
- 12.4.4 Italy - Market size and forecast 2025-2030
- 12.4.5 Spain - Market size and forecast 2025-2030
- 12.4.6 The Netherlands - Market size and forecast 2025-2030
- 12.5 APAC - Market size and forecast 2025-2030
- 12.5.1 China - Market size and forecast 2025-2030
- 12.5.2 Japan - Market size and forecast 2025-2030
- 12.5.3 India - Market size and forecast 2025-2030
- 12.5.4 South Korea - Market size and forecast 2025-2030
- 12.5.5 Australia - Market size and forecast 2025-2030
- 12.5.6 Indonesia - Market size and forecast 2025-2030
- 12.6 South America - Market size and forecast 2025-2030
- 12.6.1 Brazil - Market size and forecast 2025-2030
- 12.6.2 Argentina - Market size and forecast 2025-2030
- 12.6.3 Chile - Market size and forecast 2025-2030
- 12.7 Middle East and Africa - Market size and forecast 2025-2030
- 12.7.1 Saudi Arabia - Market size and forecast 2025-2030
- 12.7.2 UAE - Market size and forecast 2025-2030
- 12.7.3 South Africa - Market size and forecast 2025-2030
- 12.7.4 Israel - Market size and forecast 2025-2030
- 12.7.5 Turkey - Market size and forecast 2025-2030
- 12.8 Market opportunity by geography
- Market opportunity by geography ($ thousand)
- Data Tables on Market opportunity by geography ($ thousand)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Expanding long acting injectable drug demand
- Rising regenerative medicine scaffolding applications
- Advancements in targeted nanomedicine platforms
- 13.2 Market challenges
- Complex batch consistency and scaling hurdles
- Initial burst release in delivery formulations
- High cost raw material supply constraints
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Shift towards ultrapure monomer formulations
- Adoption of microfluidic continuous manufacturing
- Development of transdermal microneedle delivery
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 Ashland Inc.
- Ashland Inc. - Overview
- Ashland Inc. - Business segments
- Ashland Inc. - Key news
- Ashland Inc. - Key offerings
- Ashland Inc. - Segment focus
- SWOT
- 15.5 Bezwada Biomedical LLC
- Bezwada Biomedical LLC - Overview
- Bezwada Biomedical LLC - Product / Service
- Bezwada Biomedical LLC - Key offerings
- SWOT
- 15.6 BrightCN
- BrightCN - Overview
- BrightCN - Product / Service
- BrightCN - Key offerings
- SWOT
- 15.7 Corbion N.V.
- Corbion N.V. - Overview
- Corbion N.V. - Business segments
- Corbion N.V. - Key offerings
- Corbion N.V. - Segment focus
- SWOT
- 15.8 Creative PEGWorks
- Creative PEGWorks - Overview
- Creative PEGWorks - Product / Service
- Creative PEGWorks - Key offerings
- SWOT
- 15.9 DSM Firmenich AG
- DSM Firmenich AG - Overview
- DSM Firmenich AG - Business segments
- DSM Firmenich AG - Key offerings
- DSM Firmenich AG - Segment focus
- SWOT
- 15.10 Evonik Industries AG
- Evonik Industries AG - Overview
- Evonik Industries AG - Business segments
- Evonik Industries AG - Key news
- Evonik Industries AG - Key offerings
- Evonik Industries AG - Segment focus
- SWOT
- 15.11 Geon Performance Solutions
- Geon Performance Solutions - Overview
- Geon Performance Solutions - Product / Service
- Geon Performance Solutions - Key offerings
- SWOT
- 15.12 Gunze Ltd.
- Gunze Ltd. - Overview
- Gunze Ltd. - Product / Service
- Gunze Ltd. - Key offerings
- SWOT
- 15.13 Kureha Corp.
- Kureha Corp. - Overview
- Kureha Corp. - Business segments
- Kureha Corp. - Key offerings
- Kureha Corp. - Segment focus
- SWOT
- 15.14 Merck KGaA
- Merck KGaA - Overview
- Merck KGaA - Business segments
- Merck KGaA - Key news
- Merck KGaA - Key offerings
- Merck KGaA - Segment focus
- SWOT
- 15.15 Mitsui Chemicals Inc.
- Mitsui Chemicals Inc. - Overview
- Mitsui Chemicals Inc. - Business segments
- Mitsui Chemicals Inc. - Key offerings
- Mitsui Chemicals Inc. - Segment focus
- SWOT
- 15.16 Science and Bio Material
- Science and Bio Material - Overview
- Science and Bio Material - Product / Service
- Science and Bio Material - Key offerings
- SWOT
- 15.17 SEQENS GROUP
- SEQENS GROUP - Overview
- SEQENS GROUP - Product / Service
- SEQENS GROUP - Key offerings
- SWOT
- 15.18 Toray Industries Inc.
- Toray Industries Inc. - Overview
- Toray Industries Inc. - Business segments
- Toray Industries Inc. - Key news
- Toray Industries Inc. - Key offerings
- Toray Industries Inc. - Segment focus
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
